Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms.

Lim MS, de Leval L, Quintanilla-Martinez L.

J Hematop. 2009 Jul;2(2):65-73. doi: 10.1007/s12308-009-0034-z. Epub 2009 Jun 27.

2.

Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.

Obexer P, Hagenbuchner J, Unterkircher T, Sachsenmaier N, Seifarth C, Böck G, Porto V, Geiger K, Ausserlechner M.

Mol Biol Cell. 2009 Apr;20(7):2041-8. doi: 10.1091/mbc.E08-07-0699. Epub 2009 Feb 11.

3.

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP.

Cancer Res. 2008 Sep 15;68(18):7638-49. doi: 10.1158/0008-5472.CAN-07-6614.

4.

Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo.

Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V.

Nano Lett. 2008 Aug;8(8):2559-63. doi: 10.1021/nl801908y. Epub 2008 Jul 9.

PMID:
18611058
5.

Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.

Tran MA, Smith CD, Kester M, Robertson GP.

Clin Cancer Res. 2008 Jun 1;14(11):3571-81. doi: 10.1158/1078-0432.CCR-07-4881.

6.

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.

Zolnik BS, Stern ST, Kaiser JM, Heakal Y, Clogston JD, Kester M, McNeil SE.

Drug Metab Dispos. 2008 Aug;36(8):1709-15. doi: 10.1124/dmd.107.019679. Epub 2008 May 19.

8.

Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.

Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ.

Biochem Pharmacol. 2008 May 15;75(10):1946-58. doi: 10.1016/j.bcp.2008.02.016. Epub 2008 Mar 10.

9.

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.

Stauber RH, Mann W, Knauer SK.

Cancer Res. 2007 Jul 1;67(13):5999-6002. Review.

10.

Regulation of mitochondrial Smac/DIABLO-selective release by survivin.

Ceballos-Cancino G, Espinosa M, Maldonado V, Melendez-Zajgla J.

Oncogene. 2007 Nov 29;26(54):7569-75. Epub 2007 Jun 4.

PMID:
17546047
11.

A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessment.

Thomas J, Haseman JK, Goodman JI, Ward JM, Loughran TP Jr, Spencer PJ.

Toxicol Sci. 2007 Sep;99(1):3-19. Epub 2007 May 22. Review.

12.

Survivin and hedgehog protein expression in serrated colorectal polyps: an immunohistochemical study.

Parfitt JR, Driman DK.

Hum Pathol. 2007 May;38(5):710-7. Epub 2007 Mar 27.

PMID:
17391730
13.

Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells.

Wang J, Lv XW, Shi JP, Hu XS.

World J Gastroenterol. 2007 Feb 21;13(7):1129-34.

14.

Sphingolipids and cell death.

Morales A, Lee H, Goñi FM, Kolesnick R, Fernandez-Checa JC.

Apoptosis. 2007 May;12(5):923-39. Review.

PMID:
17294080
15.

Large granular lymphocyte leukemia.

Sokol L, Loughran TP Jr.

Oncologist. 2006 Mar;11(3):263-73. Review.

16.

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

Gelperina S, Kisich K, Iseman MD, Heifets L.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90. Epub 2005 Sep 8. Review.

17.

Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.

Kirwan RP, Leonard MO, Murphy M, Clark AF, O'Brien CJ.

Glia. 2005 Dec;52(4):309-24.

PMID:
16078232
18.

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.

Stover TC, Sharma A, Robertson GP, Kester M.

Clin Cancer Res. 2005 May 1;11(9):3465-74.

19.

ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).

Epling-Burnette PK, Bai F, Wei S, Chaurasia P, Painter JS, Olashaw N, Hamilton A, Sebti S, Djeu JY, Loughran TP.

Oncogene. 2004 Dec 9;23(57):9220-9.

PMID:
15516985
20.

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC.

J Clin Invest. 2004 Oct;114(8):1117-27.

Items per page

Supplemental Content

Write to the Help Desk